DocSym
β
Searchsearch
Search
(Q86.2) Dysmorphism due to warfarin
More details coming soon
8 830 in individuals diagnosis dysmorphism due to warfarin confirmed
2 548 deaths with diagnosis dysmorphism due to warfarin
29% mortality rate associated with the disease dysmorphism due to warfarin
Diagnosis dysmorphism due to warfarin is diagnosed Women are 0.02% more likely than Men
4 414
Men receive the diagnosis dysmorphism due to warfarin
1 801 (40.8 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
4 416
Women receive the diagnosis dysmorphism due to warfarin
747 (16.9 %)Died from this diagnosis.
Risk Group for the Disease dysmorphism due to warfarin - Men and Women aged 0
In Men diagnosis is most often set at age 0-14, 20-24, 30-34, 55-64
Less common in men the disease occurs at Age 15-19, 25-29, 35-54, 65-95+Less common in women the disease occurs at Age 10-14, 25-95+
In Women diagnosis is most often set at age 0-9, 15-24
Disease Features dysmorphism due to warfarin
Absence or low individual and public risk
Dysmorphism due to warfarin - what does this mean
Dysmorphism due to warfarin is a rare side effect of warfarin use, which causes abnormal physical features due to the drug's interference with normal development during fetal growth. warfarin is thought to interfere with the normal metabolism of vitamin k, which is essential for normal bone, cartilage, and skin development. this can lead to malformations of the face, skull, and other parts of the body.
What happens during the disease - dysmorphism due to warfarin
Dysmorphism due to warfarin is a rare condition caused by long-term use of the anticoagulant medication warfarin. warfarin interferes with vitamin k-dependent pathways, resulting in abnormal development of collagen and other proteins essential for normal tissue formation and development. this can lead to abnormal bone and cartilage formation, as well as abnormal development of other organs and tissues, resulting in physical deformities and dysmorphic features.
Clinical Pattern
More details coming soon
How does a doctor diagnose
More details coming soon
Treatment and Medical Assistance
More details coming soon
35 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Dysmorphism due to warfarin - Prevention
To prevent dysmorphism due to warfarin, it is important to closely monitor the patient's warfarin levels and adjust the dose accordingly. additionally, regular evaluation of the patient's diet and lifestyle habits should be done to ensure that they are not consuming foods or engaging in activities that may interfere with the effectiveness of the warfarin. finally, genetic testing should be considered to identify any underlying genetic factors that may increase the risk of dysmorphism.